1. Xiong, Shunjun, Wang, Yanjun, Li, Huijuan, Zhang, Xiaofang. 2019. Interaction among GRIK2 gene on epilepsy susceptibility in Chinese children. In Acta neurologica Scandinavica, 139, 540-545. doi:10.1111/ane.13089. https://pubmed.ncbi.nlm.nih.gov/30908586/
2. Zhawar, Vikramjit K, Kandpal, Raj P, Athwal, Raghbir S. 2022. Alternative Promoters of GRIK2 (GluR6) Gene in Human Carcinoma Cell Lines Are Regulated by Differential Methylation of CpG Dinucleotides. In Genes, 13, . doi:10.3390/genes13030490. https://pubmed.ncbi.nlm.nih.gov/35328043/
3. Sampaio, Aline S, Fagerness, Jesen, Crane, Jacquelyn, Pauls, David L, Stewart, S Evelyn. 2010. Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: a family-based study. In CNS neuroscience & therapeutics, 17, 141-7. doi:10.1111/j.1755-5949.2009.00130.x. https://pubmed.ncbi.nlm.nih.gov/20370803/
4. Stolz, Jacob R, Foote, Kendall M, Veenstra-Knol, Hermine E, Carvill, Gemma L, Swanson, Geoffrey T. 2021. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders. In American journal of human genetics, 108, 1692-1709. doi:10.1016/j.ajhg.2021.07.007. https://pubmed.ncbi.nlm.nih.gov/34375587/
5. Boileau, Céline, Deforges, Severine, Peret, Angélique, Mulle, Christophe, Crépel, Valérie. 2023. GluK2 Is a Target for Gene Therapy in Drug-Resistant Temporal Lobe Epilepsy. In Annals of neurology, 94, 745-761. doi:10.1002/ana.26723. https://pubmed.ncbi.nlm.nih.gov/37341588/
6. Guzmán, Yomayra F, Ramsey, Keri, Stolz, Jacob R, Narayanan, Vinodh, Swanson, Geoffrey T. 2017. A gain-of-function mutation in the GRIK2 gene causes neurodevelopmental deficits. In Neurology. Genetics, 3, e129. doi:10.1212/NXG.0000000000000129. https://pubmed.ncbi.nlm.nih.gov/28180184/
7. . 2017. Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis. In Molecular psychiatry, 23, 1181-1188. doi:10.1038/mp.2017.154. https://pubmed.ncbi.nlm.nih.gov/28761083/
8. Miyata, Haruka, Hirohashi, Yoshihiko, Yamada, Shuhei, Shinohara, Nobuo, Torigoe, Toshihiko. 2021. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy. In Cancer immunology, immunotherapy : CII, 71, 795-806. doi:10.1007/s00262-021-03025-z. https://pubmed.ncbi.nlm.nih.gov/34405274/
智鼠故事 
